Wyndgate to Provide Adventist With SafeTrace(R) Donor Management System Via Remote ASP Deployment
May 24 2006 - 10:00AM
PR Newswire (US)
DENVER, May 24 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R),
a division of Global Med Technologies(R), Inc., (OTC:GLOB)
(BULLETIN BOARD: GLOB) announced today that it has signed an
agreement with Adventist Lab Partners Blood Center to install
Wyndgate's SafeTrace(R) donor management system. Terms of the
agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) One of
the deciding factors prompting Adventist Lab Partners Blood Center
to choose Wyndgate's system was the company's ability to offer
remote deployment through Hemo-Net. Hemo-Net is a Wyndgate business
partner specializing in application service provider (ASP)
solutions for blood management and transfusion services. With
remote deployment, Adventist will be able to save the costs of
purchasing and maintaining hardware and most third-party software.
Through Hemo-Net, they will also gain continuous network
monitoring, backup systems and disaster protection. Cindy Wolfer,
RN, HP(ASCP), Regional Clinical Nurse Supervisor of Adventist Lab
Partners Blood Center, commented, "We chose the SafeTrace Donor
Management System from Wyndgate Technologies and Hemo-Net because
it offered many key elements that were a priority to us, such as
minimal up front capital costs that met our budget, an excellently
designed security system, dedicated support 24/7, proactive
monitoring and maintaining of upgrades and installs. In addition to
all of this, we were impressed by the company's professionalism and
the Wyndgate representatives' business approach to help secure the
purchase of the system in an efficient manner." "Adventist Lab
Partners Blood Center is known for compassion and a commitment to
quality care. We are honored that its blood bank team chose our
SafeTrace donor management system to help them continue to serve
their community," stated Wm. Scott Dustin, Vice President of Sales
and Marketing at Wyndgate. "Additionally, we are happy that our
partnership with Hemo-Net will help this not-for-profit
organization minimize expenses while still purchasing the system
that Adventist Lab Partners Blood Center wanted the most. We are
pleased to be involved in such a win-win situation." About
Adventist Midwest Health System Adventist Lab Partners Blood Center
is affiliated with the Adventist Midwest Health System. Adventist
Midwest Health is a not-for-profit Christian Health-care leader
committed to partnering with physicians and community to provide
whole-person care and promote wellness. Adventist Midwest Health
includes Hinsdale, La Grange Memorial, and GlenOaks Hospitals, as
well as Bolingbrook Medical Center and affiliated organizations.
Through state-of-the-art technology, comprehensive medical services
and wellness programs, 1,300 affiliated independent physicians and
5,000 employees touch hundreds of lives. About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the SafeTrace Tx advanced transfusion management system
and the SafeTrace(R) donor management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000; or Investor Relations, Paul Short, President
of Investment Strategies, LLC, +1-304-523-3252, for Global Med
Technologies, Inc. Web site: http://www.wyndgate.com/ Web site:
http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/
Copyright